Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02456727 · ClinicalTrials.gov registry record · NA

Acupuncture Approaches for Chronic Pain

A NA study, sponsored by Albert Einstein College of Medicine.

Completed
Registry status
NA
Development phase
779
Enrollment target

NCT02456727: Completed NA study, sponsored by Albert Einstein College of Medicine.

NCT02456727 is a NA study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 779 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02456727, a NA study, has completed, sponsored by Albert Einstein College of Medicine.

COMPLETED
Registry status
NA
Development phase
779 participants
Enrollment target

Study Summary

Chronic pain is a major public health problem that places many burdens on individuals, including impairment of physical and psychological functioning, lost productivity, and side effects of medications used to treat pain. There is also substantial evidence that minority populations differ both in prevalence and outcomes of chronic pain; access to care is a key component in these differences. Strong evidence now supports the use of acupuncture in the treatment of chronic pain conditions, including when provided in the primary care setting to participants from ethnically diverse, medically underserved populations. Acupuncture is slowly being integrated into pain management in many conventional health care settings, but cost and reimbursement for this service remain obstacles to offering acupuncture, especially in primary care and safety net settings. Because group acupuncture can be offered at much lower cost, demonstrating that individual and group delivery are equally effective could reduce barriers to use of this effective pain management approach. The primary aim of this study will be to evaluate whether acupuncture delivered in the group setting for participants with chronic pain is equal to acupuncture delivered in the individual setting. A secondary objective will be to use qualitative analysis to understand and describe the participants' experience of both acupuncture approaches, and to utilize this data to inform intervention delivery and dissemination, to better incorporate the participants' perspective.

Primary Outcome

The Brief Pain Inventory (BPI) short form, is a self-reported questionnaire that serves as the primary measure of how much the participants' pain interferes with daily life. Pain interference is calculated using 7 questions that range from a score of 0 (no pain) to 10 (worst pain imaginable). The scores are added and divided by 7, therefore final scores can range from 0 - 10. Having a higher mean score indicates your pain severity is worse. Investigators measured improvement in BPI pain interfer

Interventions

  • PROCEDURE Group/Community Acupuncture
  • PROCEDURE Individual Acupuncture

Trial Details

FieldValue
Enrollment Target 779 participants
Start Date 2015-05
Est. Completion 2018-03
Phase NA
Albert Einstein College of Medicine

175 total trials

What the finished NCT02456727 record still lists

NCT02456727 is an interventional study that assigns participants to a tested intervention. The registered 779 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (45% lower).

The record links to 0 conditions, and to 2 interventions - of which Group/Community Acupuncture is the first listed.

NCT02456727 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02456727 about?

NCT02456727 is a clinical study titled "Acupuncture Approaches for Chronic Pain". Chronic pain is a major public health problem that places many burdens on individuals, including impairment of physical and psychological functioning, lost productivity, and side effects of medications used to treat pain. There is also substantial evidence that minority populations differ both in pr...

What is the current status of trial NCT02456727?

This trial is currently completed. It is a NA study. The enrollment target is 779 participants. The study started on 2015-05. Estimated completion is 2018-03.

What interventions are being tested in trial NCT02456727?

The interventions under investigation include: Group/Community Acupuncture (PROCEDURE), Individual Acupuncture (PROCEDURE).

Who is sponsoring clinical trial NCT02456727?

This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02456727's enrollment target sits among peer trials

779 142nd of 2000 higher than 1,859 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05046613 · 780 participants

    Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant

  • NCT05100862 · 780 participants · Phase 3

    A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma

  • NCT05513872 · 780 participants · Phase 1

    Overcoming Nicotine Dependence to Enable Quitting

  • NCT06310031 · 780 participants · NA

    Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02456727, the US trial registry maintained by the National Library of Medicine. NCT02456727 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.